Drug Trial Radar · NCT05213676
De-implementing Inhaled Nitric Oxide for Congenital Diaphragmatic Hernia
Last checked: Nov 20, 2026Latest source record: Oct 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
900
Planned (sponsor's estimate)
Start
Nov 1, 2025
Primary completion
Oct 31, 2030
Study completion Apr 30, 2031
Sponsor
- Lead sponsor
- The University of Texas Health Science Center, HoustonAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- University of Tennessee & LeBonheur Children's Hospital (UT-LBCH); Children's Hospital of Orange County; Medical University of South Carolina Children's Health (MUSC); University of Michigan & CS Mott Children's Hospital (UM-CSMott); Randall Children's Hospital-Portland (RCH); Stanford University & Lucile Packard Children's Hospital (Stanford-LPCH); Rady Children's Hospital, San Diego; Boston Children's Hospital; Indiana University & Riley Children's Hospital (IU-RiCH); Norton Children's Hospital; University of Utah & Primary Children's Hospital (Utah-PCH); University of Washington & Seattle Children's Hospital (UW-SCH); University of Alabama & Children's Hospital of Alabama (UAB-CoA); University of Arkansas; Vanderbilt University Medical Center; University of Southern California & Children's Hospital Los Angeles (USC-CHLA); Emory University & Children's Healthcare of Atlanta (CHOA); Children's Hospital Colorado
- First posted
- Jan 28, 2022
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 0 months, up to 1 month
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine if de-implementation of inhaled nitric oxide (iNO) in the post-natal resuscitation/stabilization phase affects the composite outcome of extracorporeal life support (ECLS) use and/or mortality, as well as ECLS use, mortality, and/or oxygenation in congenital diaphragmatic hernia (CDH) newborns and to establish the cost-effectiveness of de-implementing iNO as a therapy in the postnatal resuscitation/stabilization phase of CDH management, which will be assessed as the incremental health system costs (savings) per prevented ECLS use and/or death.
Conditions
- Congenital Diaphragmatic Hernia
Interventions
Inhaled Nitric Oxide (iNO) useDrug
The center will use iNO per their usual protocol in the initial resuscitation period (defined as birth through stabilization and CDH repair). No center will alter any component of their standard clinical practice guideline or protocol governing CDH care.
De-implementation of Inhaled Nitric Oxide (iNO) useOther
The center will stop using iNO in the initial resuscitation period (defined as birth through stabilization and CDH repair).
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of participants who require Extracorporeal Life Support (ECLS) and/or who die prior to dischargeTime frame: from birth through hospital discharge (up to 12 months from birth)
Locations
19 sites in 1 country. Site status is shown where the registry gives one.
University of Alabama & Children's Hospital of Alabama (UAB-CoA)
Birmingham, Alabama · Recruiting
University of Arkansas & Arkansas Children's Hospital (UA-ACH)
Little Rock, Arkansas · Recruiting
University of California-Irvine & Children's Hospital of Orange County (UC-CHOC)
Irvine, California · Recruiting
University of Southern California & Children's Hospital Los Angeles (USC-CHLA)
Los Angeles, California · Recruiting
Stanford University & Lucile Packard Children's Hospital (Stanford-LPCH)
Palo Alto, California · Recruiting
University of California, San Diego & Rady Children's Hospital (UCSD-Rady)
San Diego, California · Recruiting
University of Colorado & Children's Hospital of Colorado (CU-CHC)
Aurora, Colorado · Recruiting
Emory University & Children's Healthcare of Atlanta (CHOA)
Atlanta, Georgia · Recruiting
Indiana University & Riley Children's Hospital (IU-RiCH)
Indianapolis, Indiana · Recruiting
University of Louisville & Norton Children's Hospital (UL-NCH)
Louisville, Kentucky · Recruiting
Harvard University & Boston Children's Hospital (Harvard-BCH)
Boston, Massachusetts · Recruiting
University of Michigan & CS Mott Children's Hospital (UM-CSMott)
Ann Arbor, Michigan · Recruiting
Randall Children's Hospital-Portland (RCH)
Portland, Oregon · Recruiting
Medical University of South Carolina Children's Health (MUSC)
Charleston, South Carolina · Recruiting
University of Tennessee & LeBonheur Children's Hospital (UT-LBCH)
Memphis, Tennessee · Recruiting
Vanderbilt University & Vanderbilt University Medical Center (VUMC)
Nashville, Tennessee · Recruiting
The University of Texas Health Science Center at Houston
Houston, Texas · Recruiting
University of Utah & Primary Children's Hospital (Utah-PCH)
Salt Lake City, Utah · Recruiting
University of Washington & Seattle Children's Hospital (UW-SCH)
Seattle, Washington · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.